JP7835772B2 - 薬剤の治療効果を測定するためのシステム及び方法 - Google Patents

薬剤の治療効果を測定するためのシステム及び方法

Info

Publication number
JP7835772B2
JP7835772B2 JP2023550149A JP2023550149A JP7835772B2 JP 7835772 B2 JP7835772 B2 JP 7835772B2 JP 2023550149 A JP2023550149 A JP 2023550149A JP 2023550149 A JP2023550149 A JP 2023550149A JP 7835772 B2 JP7835772 B2 JP 7835772B2
Authority
JP
Japan
Prior art keywords
patients
trial
dataset
disease
covariates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2023550149A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024506976A (ja
JP2024506976A5 (https=
Inventor
ブロックシュテット、エッケハルト
アブスニナ、アリ
リンク、ジャスミン
ペレス－ピタルク、アレハンドロ
シュヴァルツ、フィリップ
ストック、クリスチャン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BI X GmbH
Original Assignee
BI X GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BI X GmbH filed Critical BI X GmbH
Publication of JP2024506976A publication Critical patent/JP2024506976A/ja
Publication of JP2024506976A5 publication Critical patent/JP2024506976A5/ja
Application granted granted Critical
Publication of JP7835772B2 publication Critical patent/JP7835772B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Primary Health Care (AREA)
  • Data Mining & Analysis (AREA)
  • Biomedical Technology (AREA)
  • Databases & Information Systems (AREA)
  • Pathology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
JP2023550149A 2021-02-22 2022-02-08 薬剤の治療効果を測定するためのシステム及び方法 Active JP7835772B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP21158462 2021-02-22
EP21158462.8 2021-02-22
EP21161795 2021-03-10
EP21161795.6 2021-03-10
PCT/EP2022/052966 WO2022175131A1 (en) 2021-02-22 2022-02-08 System and method for measuring the treatment effect of a drug

Publications (3)

Publication Number Publication Date
JP2024506976A JP2024506976A (ja) 2024-02-15
JP2024506976A5 JP2024506976A5 (https=) 2025-02-13
JP7835772B2 true JP7835772B2 (ja) 2026-03-25

Family

ID=81326117

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023550149A Active JP7835772B2 (ja) 2021-02-22 2022-02-08 薬剤の治療効果を測定するためのシステム及び方法

Country Status (4)

Country Link
US (1) US20230395227A1 (https=)
EP (1) EP4295369B1 (https=)
JP (1) JP7835772B2 (https=)
WO (1) WO2022175131A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7835772B2 (ja) * 2021-02-22 2026-03-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 薬剤の治療効果を測定するためのシステム及び方法
CN117954114B (zh) * 2024-03-26 2024-08-13 北京大学 基于倾向性评分和幂先验的真实世界数据借用方法及系统

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019063377A (ja) 2017-10-03 2019-04-25 株式会社国際電気通信基礎技術研究所 哺乳動物におけるうつ病の病態プロファイルを検出するバイオマーカーとその利用
US20200105380A1 (en) 2018-10-02 2020-04-02 Origent Data Sciences, Inc. Systems and methods for designing clinical trials

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2650562A1 (en) * 2005-04-25 2006-11-02 Caduceus Information Systems Inc. System for development of individualised treatment regimens
US20150315651A1 (en) * 2013-10-17 2015-11-05 Biometheus LLC Methods and kits for determining a placebo profile in subjects for clinical trials and for treatment of patients
JP7305656B2 (ja) * 2018-01-17 2023-07-10 アンラーン．エーアイ， インコーポレイテッド 確率分布をモデル化するためのシステムおよび方法
US20200265940A1 (en) * 2019-02-15 2020-08-20 The Regents Of The University Of California Predictive treatment controller for vedolizumab
US11670424B2 (en) * 2020-09-24 2023-06-06 International Business Machines Corporation Evaluation of reduction of disease risk and treatment decision
JP7835772B2 (ja) * 2021-02-22 2026-03-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 薬剤の治療効果を測定するためのシステム及び方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019063377A (ja) 2017-10-03 2019-04-25 株式会社国際電気通信基礎技術研究所 哺乳動物におけるうつ病の病態プロファイルを検出するバイオマーカーとその利用
US20200105380A1 (en) 2018-10-02 2020-04-02 Origent Data Sciences, Inc. Systems and methods for designing clinical trials

Also Published As

Publication number Publication date
EP4295369B1 (en) 2024-12-25
JP2024506976A (ja) 2024-02-15
EP4295369A1 (en) 2023-12-27
WO2022175131A1 (en) 2022-08-25
US20230395227A1 (en) 2023-12-07

Similar Documents

Publication Publication Date Title
JP7738717B2 (ja) 臨床試験をデザインするシステムと方法
Austin et al. Variance estimation when using propensity‐score matching with replacement with survival or time‐to‐event outcomes
Wasko et al. Propensity‐adjusted association of methotrexate with overall survival in rheumatoid arthritis
Sweeting et al. The use of repeated blood pressure measures for cardiovascular risk prediction: a comparison of statistical models in the ARIC study
Puhan et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index
Chester Wasko et al. Prednisone use and risk of mortality in patients with rheumatoid arthritis: moderation by use of disease‐modifying antirheumatic drugs
Burden et al. An evaluation of exact matching and propensity score methods as applied in a comparative effectiveness study of inhaled corticosteroids in asthma
Pirracchio et al. The balance super learner: a robust adaptation of the super learner to improve estimation of the average treatment effect in the treated based on propensity score matching
Fainberg et al. Forced vital capacity trajectories in patients with idiopathic pulmonary fibrosis: a secondary analysis of a multicentre, prospective, observational cohort
Hahn et al. Understanding comorbidity profiles and their effect on treatment and survival in patients with colorectal cancer
Schmidli et al. Estimands for recurrent event endpoints in the presence of a terminal event
DeConde et al. Development of a clinically relevant endoscopic grading system for chronic rhinosinusitis using canonical correlation analysis
Chaves et al. Variation of stroke-associated pneumonia in stroke units across England and Wales: a registry-based cohort study
Plesner et al. The prognostic significance of lung function in stable heart failure outpatients
JP7835772B2 (ja) 薬剤の治療効果を測定するためのシステム及び方法
Lopes et al. Adverse event load, onset, and maximum grade: a novel method of reporting adverse events in cancer clinical trials
Fisch et al. Predictors of significant worsening of patient‐reported fatigue over a 1‐month timeframe in ambulatory patients with common solid tumors
Burger et al. Early addition of selexipag to double therapy for pulmonary arterial hypertension
Golpe et al. Development and validation of a prognostic index (BODEXS90) for mortality in stable chronic obstructive pulmonary disease
Zhou et al. Treatment Landscape for Older Men With Metastatic Hormone‐Sensitive Prostate Cancer in the United States
CN116806357A (zh) 用于测量药物的治疗效果的系统和方法
Todd et al. Improving mortality models in the ICU with high-frequency data
Shang et al. Secondary Analysis of Randomized Controlled Trials: Methodological Considerations and Best Practices
Webb et al. Examining heart failure outcomes amid housing insecurity
Mande et al. Assessment of a mobile health iphone app for semiautomated self-management of chronic recurrent medical conditions using an N-of-1 trial framework: feasibility pilot study

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240524

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250204

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250204

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20251125

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20251128

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260119

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260303

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260312

R150 Certificate of patent or registration of utility model

Ref document number: 7835772

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150